课题基金 / 基金详情

Novel antioxidant therapeutics for sulfur mustard toxicity (U54)

Novel antioxidant therapeutics for sulfur mustard toxicity (U54)
针对硫芥毒性的新型抗氧化疗法 (U54)
批准号:
7225100
负责人:
Carl W White
金额:
$154.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-29 至 2011-05-31

项目摘要

项目成果

Carl W White的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Description (provided by applicant): Sulfur mustard (HD, mustard gas) is the most highly utilized chemical weapon in history, and currently it poses a serious threat to both military and civilian populations. In addition to stockpiles, HD remains one of the easiest chemical weapons to make in large quantities, and it is included in the list of likely choices for terrorist organizations. HD can be a severely debilitating agent for those exposed to it. The primary organs affected by HD are the lungs, skin and eyes. It results in acute airway edema, ARDS, bronchopneumonia, tracheobronchomalacia and/or airway stenosis, bronchiolitis obliterans, bronchiectasis, pulmonary fibrosis, asthma, and other respiratory complications. There are no specific treatments or antidotes for HD nor preventive medications to minimize its effects. Decontamination and supportive care are the only interventions recommended by current medical guidelines and more of these protect the airways. Decontamination is effective for skin and eyes only if enacted very early (< 5 minutes). Unfortunately, recognition of the problem usually does not occur within this timeframe. We hypothesize that supplementation or augmentation of airway mono- or dithiols will prevent or limit sulfur mustard toxicity. Using an animal model employing 2-chloroethyl ethyl sulfide (CEES, "half-mustard"), a less toxic analog of sulfur mustard, we will: 1) Determine airway inflammation, pro-inflammatory cytokines, and principal thiols following half-mustard aerosolization in rat, 2) evaluate effectiveness of oral and aerosolized mono- (GSH) and dithiols (lipoic acid, thioredoxin) in attenuating halfmustard lung injury (inflammation, cytokines, thiols), 3) develop novel compounds to stimulate mono- and dithiol efflux into lung epithelial lining fluid, and 4) examine the efficacy of these novel compounds in vivo. The latter studies will help us establish optimal compounds, route and mode of delivery, pharmacokinetics, bioavailability, and toxicology. Our laboratories have exceptional experience in measurement of the relevant, potentially protective thiol compounds to be evaluated. We anticipate these studies will lead to testing of the most effective compounds using authentic mustard gas at appropriate facilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of vaping on COVID-19 infection
  • 批准号:
    10176655
  • 项目类别:
  • 资助金额:
    $18.24万
  • 财政年份:
    2016
  • 负责人:
    Carl W White
  • 依托单位:
Development of antidotes for toxic gases
  • 批准号:
    9145045
  • 项目类别:
  • 资助金额:
    $343.54万
  • 财政年份:
    2016
  • 负责人:
    Carl W White
  • 依托单位:
Development of antidotes for toxic gases
  • 批准号:
    9564911
  • 项目类别:
  • 资助金额:
    $323.1万
  • 财政年份:
    2016
  • 负责人:
    Carl W White
  • 依托单位:
New Developments in Chemical Countermeasures: CounterACT 2018
  • 批准号:
    9490163
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2016
  • 负责人:
    Carl W White
  • 依托单位: